These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Meeting report: Public health in reverse? Frischknecht F Biotechnol J; 2006 Feb; 1(2):133-4. PubMed ID: 16892241 [No Abstract] [Full Text] [Related]
4. Australia sets priorities for future research. Dennis C Nature; 2002 Dec; 420(6916):597. PubMed ID: 12478255 [No Abstract] [Full Text] [Related]
5. The limits of law in the protection of public health and the role of public health ethics. Martin R Public Health; 2006 Oct; 120 Suppl():71-7; discussion 77-80. PubMed ID: 16973195 [No Abstract] [Full Text] [Related]
6. Straight talk with ... Agnès Saint Raymond. Interview by Genevive Bjorn. Saint Raymond A Nat Med; 2009 Apr; 15(4):354-5. PubMed ID: 19350000 [No Abstract] [Full Text] [Related]
7. Straight talk with...Joan Scott by Genevive Bjorn. Scott J Nat Med; 2009 Nov; 15(11):1236-7. PubMed ID: 19893539 [No Abstract] [Full Text] [Related]
8. Comment: interactions between the medical profession and the pharmaceutical industry in Australia. Kerridge I Australas Psychiatry; 2008 Jun; 16(3):166-8. PubMed ID: 18568620 [No Abstract] [Full Text] [Related]
10. Pharmaceuticals and medical devices: business practices. Jones TM Issue Brief Health Policy Track Serv; 2009 Jan; ():1-54. PubMed ID: 19297719 [No Abstract] [Full Text] [Related]
11. [The Public Health National plan: thesis, antithesis, synthesis]. Segura O Biomedica; 2008 Jun; 28(2):17-20. PubMed ID: 18719717 [No Abstract] [Full Text] [Related]
12. Changes in the rules now governing Italy's drug industry. Dompé S Nature; 2008 Aug; 454(7208):1049. PubMed ID: 18756232 [No Abstract] [Full Text] [Related]
13. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers. Mehta RS Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922 [No Abstract] [Full Text] [Related]
14. Engaging the values-based ethical dilemmas in harm minimization: a response to Weatherburn. Fry CL; Irwin K Addiction; 2009 May; 104(5):862-3; author reply 863-4. PubMed ID: 19413798 [No Abstract] [Full Text] [Related]
16. More than hot air. Nature; 2009 Apr; 458(7241):945-6. PubMed ID: 19396090 [No Abstract] [Full Text] [Related]
17. Straight talk with... Alan Gillespie Interviewed by Genevive Bjorn. Gillespie A Nat Med; 2008 Jun; 14(6):598-9. PubMed ID: 18535568 [No Abstract] [Full Text] [Related]
18. Global health challenges in the pharmaceutical world. Abraham J Health Econ Policy Law; 2009 Jan; 4(Pt 1):115-27. PubMed ID: 19099620 [No Abstract] [Full Text] [Related]
19. Ethicists express concern about influence of PR firm on flu experts. Sweet M BMJ; 2010 Sep; 341():c5183. PubMed ID: 20876150 [No Abstract] [Full Text] [Related]
20. [Government control of medical and pharmaceutical activity is in single medical space of Ukraine (theoretical and methodological foundations)]. Radysh Ia Lik Sprava; 2012; (3-4):113-23. PubMed ID: 23356150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]